Tous Actualités
Suivre
Abonner november AG

november AG

euro adhoc: november AG
Personnel
Management of november AG strengthened with Appointment of New CFO

  Disclosure announcement transmitted by euro adhoc.
  The issuer is responsible for the content of this announcement.
20.09.2005
Erlangen, 20 September 2005. The Supervisory Board of  november AG
today appointed with immediate effect Astrid Dickert, Bachelor of
Commerce, as Chief  Financial Officer (CFO) of the company. The core
areas of her responsibility and authority will be accounting,
controlling, investor relations and human resources.
Ms Dickert joined november AG in 2000 as staff accountant, was
promoted in  2003 to Director of Accounting and Controlling and since
June of this year headed the complete Financial Department.
Explanations: "The Supervisory Board of november AG, based its
decision on its trust in the strong background and experience of Ms
Dickert, in deciding for in-house talent to fill the vacant position.
With this action, november AG complies with requests of its investors
and promotes a more efficient further restructuring into a bio- and
nanotechnology holding company for more transparency. With this new
appointment, the CFO will attend to the capital markets and
coordinate the M&A activity of the Company in a more effective way",
stated Dr. Wolf M. Bertling, CEO of november AG.
november AG,  Erlangen, Germany, is listed at the Prime Standard of
the Frankfurt Stock Exchange, ISIN DE0006762909, symbol (NBX).
November AG is a Bio- and Nanotechnology holding company that
develops and invests in new technologies. The group comprises among
others the subsidiaries identif GmbH (brand protection & product
safety), directif GmbH (Medtech, diagnostics of nucleic acids) and
PEQLAB Biotechnologie GmbH (the link between research in molecular
biology and the market).
end of announcement                               euro adhoc 20.09.2005 14:10:30

Further inquiry note:

Andrea Steuer
Manager Investor Relations/Public Relations
Tel.: +49(0)9131-75088-868
Fax: +49 (0)9131-75088-999
E-Mail: steuer@november.de

Branche: Biotechnology
ISIN: DE0006762909
WKN: 676290
Index: CDAX, Technologie All Share, Prime All Share, Prime Standard
Börsen: Frankfurter Wertpapierbörse / regulated dealing
Berliner Wertpapierbörse / free trade
Baden-Württembergische Wertpapierbörse / free trade
Börse Düsseldorf / free trade
Niedersächsische Börse zu Hannover / free trade
Bayerische Börse / free trade
Bremer Wertpapierbörse (BWB) / free trade

Plus de actualités: november AG
Plus de actualités: november AG